Jack Tolley, a 20-year-old student from Stourbridge, left university and moved back home after struggling to access his epilepsy medication. Jack relies on 17 daily tablets to manage his condition, but widespread shortages forced him to travel between pharmacies across Bournemouth. Without the ability to drive, he had to navigate public transport while facing the constant risk of seizures.
His mother, Rachel Murphy, often spent weeks trying to secure his prescriptions. She describes the situation as frightening, especially knowing that his life depends on consistent access to these drugs. For patients with severe conditions, missing a single dose can trigger life-threatening health complications.
Pharmacists are feeling the strain as well. Sanjeev Panesar, a superintendent pharmacist in Birmingham, describes the current medicine supply situation as the worst he has seen in his career. He notes that pharmacies are frequently forced to source medications at prices higher than what the government reimburses, making the current supply chain model unsustainable for small businesses.
The National Pharmacy Association reports that record shortages now affect common medications, including those for blood pressure and pain relief. The Epilepsy Society is calling for emergency government supplies to protect patients with cliff-edge conditions. This follows multiple reports where coroners issued prevention of future deaths notices after young men died while unable to obtain their epilepsy drugs.
While the Department of Health maintains that most medicines remain in good supply, families and pharmacists on the ground disagree. The government points to a 520 million pound investment in the Life Sciences Innovative Manufacturing Fund as a long-term solution. For now, patients are left to coordinate with doctors and pharmacists to find alternatives, though health advocates warn that switching medication brands can be dangerous for those with epilepsy.